The associastion between the expression of solute carrier transporters and the prognosis of pancreatic cancer

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F13%3A33145222" target="_blank" >RIV/61989592:15110/13:33145222 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1007/s00280-013-2246-2" target="_blank" >http://dx.doi.org/10.1007/s00280-013-2246-2</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s00280-013-2246-2" target="_blank" >10.1007/s00280-013-2246-2</a>

Result language
angličtina
Original language name
The associastion between the expression of solute carrier transporters and the prognosis of pancreatic cancer
Original language description
The aim of this study was to investigate the prognostic significance of fourteen anticancer drug-relevant solute carrier transporters (SLCs) in pancreatic cancer in the context of clinical-pathological characteristics and the KRAS mutation status of tumors. Tumors and non-neoplastic pancreatic tissues were obtained from 32 histologically verified patients with pancreatic ductal adenocarcinoma. The transcript profile of SLCs was assessed using quantitative real-time PCR. KRAS mutations in exon 2 were assessed by high-resolution melting analysis and confirmed by sequencing.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)